Collaboration between Qiagen and Incyte to develop a novel diagnostic panel, leveraging FDA approvals for market access in the US.

The entities involved

• Qiagen →

  company

  • Berenberg Bank has set a target price for Qiagen shares.Sat 13:56
  • Private equity is seeking to acquire Qiagen, while Abu Dhabi Investment Authority (ADIA) holds subsidiary interest in EQT.Thu 14:47
• Incyte →

  American pharmaceutical company

  • Genmab and Incyte have entered into a collaboration to evaluate new cancer treatments.Sat 11:54
  • Truist Financial, Leerink partners, and Morgan Stanley have raised price targets and weighed in on Incyte stock.Sat 08:28
• FDA →
  • The illegal U.S. vape market is estimated to be worth $9 billion, fueled by unauthorized imports from China, while products must meet FDA authorization standards.Sun 20:36
  • VDPHL01 and Veradermics, Incorporated are seeking FDA approval for their lead therapies targeting hair loss.Sun 20:31

Related events

• Arise is seeking FDA approval for a drug as of October 7, 2026.Oct 7
• FDA and Pfizer are seeking regulatory approval for their products.Aug 29
• FDA is willing to review updated submissions, while biotech hubs leverage AI to ease clinical development bottlenecks.Aug 28
• FDA, LabCorp, and Charles River Laboratories formed a collaboration to evaluate the potential for medicine abuse.Thu 22:25
• FDA approval enables commercial availability for a product associated with Indianapolis.Oct 6